Krishnamoorthy V, Hamdani F, Shukla P, Rao R, Anaitullah S, Biligiri K
Life Sci Alliance. 2024; 8(3.
PMID: 39741006
PMC: 11707394.
DOI: 10.26508/lsa.202402871.
Krivec N, Couvreu de Deckersberg E, Lei Y, Al Delbany D, Regin M, Verhulst S
Cell Death Dis. 2024; 15(11):852.
PMID: 39572522
PMC: 11582570.
DOI: 10.1038/s41419-024-07236-x.
Al Delbany D, Ghosh M, Krivec N, Huyghebaert A, Regin M, Duong M
Cells. 2024; 13(16).
PMID: 39195283
PMC: 11353044.
DOI: 10.3390/cells13161395.
Stavish D, Price C, Gelezauskaite G, Alsehli H, Leonhard K, Taapken S
Stem Cell Reports. 2024; 19(8):1217-1232.
PMID: 38964325
PMC: 11368687.
DOI: 10.1016/j.stemcr.2024.06.003.
Vales J, Barbaric I
Bioessays. 2024; 46(12):e2400062.
PMID: 38873900
PMC: 11589660.
DOI: 10.1002/bies.202400062.
High prevalence of acquired cancer-related mutations in 146 human pluripotent stem cell lines and their differentiated derivatives.
Lezmi E, Jung J, Benvenisty N
Nat Biotechnol. 2024; 42(11):1667-1671.
PMID: 38195986
DOI: 10.1038/s41587-023-02090-2.
Gains of 20q11.21 in human pluripotent stem cells: Insights from cancer research.
Krivec N, Ghosh M, Spits C
Stem Cell Reports. 2023; 19(1):11-27.
PMID: 38157850
PMC: 10828824.
DOI: 10.1016/j.stemcr.2023.11.013.
EpiTyping: analysis of epigenetic aberrations in parental imprinting and X-chromosome inactivation using RNA-seq.
Sarel-Gallily R, Keshet G, Kinreich S, Haim-Abadi G, Benvenisty N
Nat Protoc. 2023; 18(12):3881-3917.
PMID: 37914783
DOI: 10.1038/s41596-023-00898-5.
Human and Pig Pluripotent Stem Cells: From Cellular Products to Organogenesis and Beyond.
Xuan Y, Petersen B, Liu P
Cells. 2023; 12(16).
PMID: 37626885
PMC: 10453631.
DOI: 10.3390/cells12162075.
DPPA5A suppresses the mutagenic TLS and MMEJ pathways by modulating the cryptic splicing of and in mouse embryonic stem cells.
Jiang F, Wang L, Dong Y, Nie W, Zhou H, Gao J
Proc Natl Acad Sci U S A. 2023; 120(30):e2305187120.
PMID: 37459543
PMC: 10372678.
DOI: 10.1073/pnas.2305187120.
Current Status and Future Perspectives on Stem Cell-Based Therapies for Parkinson's Disease.
Cha Y, Park T, Leblanc P, Kim K
J Mov Disord. 2023; 16(1):22-41.
PMID: 36628428
PMC: 9978267.
DOI: 10.14802/jmd.22141.
A reference human induced pluripotent stem cell line for large-scale collaborative studies.
Pantazis C, Yang A, Lara E, McDonough J, Blauwendraat C, Peng L
Cell Stem Cell. 2022; 29(12):1685-1702.e22.
PMID: 36459969
PMC: 9782786.
DOI: 10.1016/j.stem.2022.11.004.
The Tumorigenic Potential of Human Pluripotent Stem Cells.
Lezmi E, Benvenisty N
Stem Cells Transl Med. 2022; 11(8):791-796.
PMID: 35679163
PMC: 9397652.
DOI: 10.1093/stcltm/szac039.
Assessing Cell Competition in Human Pluripotent Stem Cell (hPSC) Cultures.
Price C, Barbaric I
Curr Protoc. 2022; 2(5):e435.
PMID: 35621694
PMC: 9325404.
DOI: 10.1002/cpz1.435.
Correlation Between Genetic Abnormalities in Induced Pluripotent Stem Cell-Derivatives and Abnormal Tissue Formation in Tumorigenicity Tests.
Yamamoto T, Sato Y, Yasuda S, Shikamura M, Tamura T, Takenaka C
Stem Cells Transl Med. 2022; 11(5):527-538.
PMID: 35445254
PMC: 9154342.
DOI: 10.1093/stcltm/szac014.
Whole-genome analysis of human embryonic stem cells enables rational line selection based on genetic variation.
Merkle F, Ghosh S, Genovese G, Handsaker R, Kashin S, Meyer D
Cell Stem Cell. 2022; 29(3):472-486.e7.
PMID: 35176222
PMC: 8900618.
DOI: 10.1016/j.stem.2022.01.011.
The Impact of Acquired Genetic Abnormalities on the Clinical Translation of Human Pluripotent Stem Cells.
Keller A, Spits C
Cells. 2021; 10(11).
PMID: 34831467
PMC: 8625075.
DOI: 10.3390/cells10113246.
Large-scale analysis of imprinting in naive human pluripotent stem cells reveals recurrent aberrations and a potential link to FGF signaling.
Keshet G, Benvenisty N
Stem Cell Reports. 2021; 16(10):2520-2533.
PMID: 34597600
PMC: 8514966.
DOI: 10.1016/j.stemcr.2021.09.002.
Study of cellular heterogeneity and differential dynamics of autophagy in human embryonic kidney development by single-cell RNA sequencing.
Wen-Jin C, Xiu-Wu P, Jian C, Da X, Jia-Xin C, Wei-Jie C
Cancer Cell Int. 2021; 21(1):460.
PMID: 34461918
PMC: 8404318.
DOI: 10.1186/s12935-021-02154-w.
Genetically variant human pluripotent stem cells selectively eliminate wild-type counterparts through YAP-mediated cell competition.
Price C, Stavish D, Gokhale P, Stevenson B, Sargeant S, Lacey J
Dev Cell. 2021; 56(17):2455-2470.e10.
PMID: 34407428
PMC: 8443275.
DOI: 10.1016/j.devcel.2021.07.019.
